Chemoinformaics analysis of Dibutyl trisulfide
| Molecular Weight | 210.433 | nRot | 8 |
| Heavy Atom Molecular Weight | 192.289 | nRig | 0 |
| Exact Molecular Weight | 210.057 | nRing | 0 |
| Solubility: LogS | -5.557 | nHRing | 0 |
| Solubility: LogP | 3.964 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 34.0623 |
| nHD | 0 | BPOL | 20.5177 |
| QED | 0.424 |
| Synth | 2.864 |
| Natural Product Likeliness | 0.388 |
| NR-PPAR-gamma | 0.051 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.008 |
| Pgp-sub | 0.017 |
| HIA | 0.003 |
| CACO-2 | -4.428 |
| MDCK | 0.0000238 |
| BBB | 0.602 |
| PPB | 0.866202 |
| VDSS | 1.304 |
| FU | 0.0708747 |
| CYP1A2-inh | 0.908 |
| CYP1A2-sub | 0.919 |
| CYP2c19-inh | 0.976 |
| CYP2c19-sub | 0.876 |
| CYP2c9-inh | 0.825 |
| CYP2c9-sub | 0.89 |
| CYP2d6-inh | 0.209 |
| CYP2d6-sub | 0.769 |
| CYP3a4-inh | 0.109 |
| CYP3a4-sub | 0.181 |
| CL | 12.01 |
| T12 | 0.119 |
| hERG | 0.199 |
| Ames | 0.382 |
| ROA | 0.125 |
| SkinSen | 0.95 |
| Carcinogencity | 0.343 |
| EI | 0.993 |
| Respiratory | 0.961 |
| NR-Aromatase | 0.044 |
| Antiviral | No |
| Prediction | 0.9178 |